why choose us

First received: March 13, 2023

Clinical Trial: Registry of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Relapsed/Refractory Acute Lymphoblastic Leukemia

Study Type: OBSERVATIONAL


Official Title: Observatory for Patients Treated for Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia With Oncogenetic Features.

Brief Summary: In order to improve the outcome of relapsed and/or refractory T-cell precursor acute lymphoblastic leukemia (T-ALL) patients, and to facilitate the use of oncogenetic targeted therapies in these patients, we set up an observational cohort, collecting clinical and biological information's from patients with T-ALL in relapse or refractory, as well as the use or not of a targeted therapy.The analysis of the cohort will allow us to evaluate the impact of this therapeutic strategies on the patients'…

Read more